Pharma startup Pharmaoffer is fighting global medicine shortage through pharmaceutical supply chain transformation
The global pharmaceutical market is over $1 trillion marks and is projected to grow at 6.3% CAGR through 2022. With all the technology advancements in drug research and medicine, the pharmaceutical supply chain is still lagging behind in digital transformation compared to other industries. Getting the required ingredients and raw materials from suppliers to the buyer is rife with complexity and cumbersome processes. It is a market that is ripe for disruption. Enter Pharma offer, a Dutch pharma startup and an online marketplace for pharmaceutical raw materials that is streamlining the entire pharma supply chain process and connecting buyers with suppliers of pharmaceutical ingredients (APIs, Excipients, and Intermediates). Today, the company announced it's collaborating with pharmaceutical suppliers to resolve medicine shortages around the world. Through its global B2B platform, suppliers of pharmaceutical raw materials can offer their products directly to the buyers. Pharmaoffer enables producers of medicines to easily find newly qualified suppliers for their raw material needs. Pharmaoffer simplifies and transforms the supply chain process by cutting out the middleman and provides a transparent solution that reduces expenses and unnecessary delays in the supply chain by giving more control to all parties involved. Through its platform, Pharmaoffer has successfully connected buyers and supplier from 172 countries.